Ribbon Acquisition Corp.

(Incorporated in Japan) We are a new blank check company. Angshuman (Bubai) Ghosh is our CEO and the chairman of the board of directors. He has over 27 years of experience in financial and consulting services and more than 19 years of experience in international business coordination, responsible for operations management, IT integration project management and […]

August 28, 2024 Read More

CeriBell, Inc.

We developed an EEG (electroencephalography) platform to diagnose and monitor patients at risk of seizures.(Incorporated in Delaware) We are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet […]

August 26, 2024 Read More

HTL Group Ltd.

Our mission is to become the leading upholstered furniture supplier in India and the Middle East. (Incorporated in the British Virgin Islands) We are a fast-growing furniture supplier principally engaged in the sale and distribution of upholstered furniture in India through Newcentury Trading, our Operating Subsidiary. We are engaged in the sales and distribution of (i) mainly […]

Read More

MBX Biosciences

We are a clinical-stage biopharmaceutical company developing novel precision peptide therapies to treat endocrine and metabolic diseases. (Incorporated in Delaware) Our leading drug candidate, MBX 2109, is a parathyroid hormone peptide designed as a potential long-acting hormone replacement therapy for chronic hypoparathyroidism.  Our company was founded by global leaders with a transformative approach to peptide […]

August 23, 2024 Read More

Job Aire Group (Withdrawn)

Note: Job Aire Group withdrew its IPO plans in a letter to the SEC dated April 12, 2025. We are a 16-year-old professional services company with demonstrated expertise and excellence in providing comprehensive staffing solutions across various facets of the aviation industry. (Incorporated in  Arizona)  Over the years, we have built a strong reputation for […]

Read More

Founder Group Limited

Our mission is to provide customers with innovative solar installation services, promote eco-friendly resources, and achieve carbon neutrality. (Incorporated in the British Virgin Islands) We are a pure-play end-to-end EPCC solutions provider for solar PV facilities in Malaysia. Our primary focus is on two key segments: large-scale solar projects and commercial and industrial (C&I) solar projects. (Note: In […]

Read More

Rising Dragon Acquisition Corp.

We are a newly organized blank check company. (Incorporated in the Cayman Islands)  We intend to seek to acquire small cap businesses exhibiting substantial potential in emerging markets driven by innovative technologies or novel business models. We believe these industries are attractive for a number of reasons, including: they represent attractive markets, which are characterized […]

Read More

Launch Two Acquisition Corp.

We are a newly incorporated blank check company. (Incorporated in the Cayman Islands) We may search in any sector and in any geographic region for a target company for an acquisition or an initial business combination. James J. McEntee, III has served as our Chief Executive Officer and Chairman since inception. He is the Chairman of the Board […]

August 22, 2024 Read More

Bicara Therapeutics

We are a clinical-stage biopharmaceutical company targeting head and neck squamous cell cancer with our leading drug candidate, ficerafusp alfa, a bifunctional antibody to target solid tumors. (Incorporated in Delaware) We are evaluating ficerafusp alfa in an ongoing Phase 1/1b clinical trial in the U.S. to treat patients with head and neck squamous cell cancer. […]

Read More

Zenas BioPharma Inc.

We are a clinical biotech company developing new therapies for MS (multiple sclerosis) and other autoimmune disorders. (Incorporated in Delaware) We are a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies for patients in need.  Our lead I&I (immunology and inflammation) product candidate, obexelimab, is […]

Read More
Page 25 of 301« First...1020...2324252627...304050...Last »